by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
by Truveta Research | Sep 12, 2022 | Research, Research Insights
At the start of the pandemic, clinicians around the world were struggling for answers. No one knew the best ways to treat patients with COVID-19 infections – when to intubate, which treatments actually work, and more. That’s why more than 20 U.S. health systems have...
by Truveta Research | Sep 8, 2022 | Research, Research Insights
The pandemic has fundamentally changed the way we live. For many of us, it has also changed our interactions with the world around us. Previous reports have shown how living through the pandemic has impacted mental health [1,2], including how a COVID-19 diagnosis...
by Truveta staff | Jun 21, 2022 | News
Real World Data on a grand scale empowers Pfizer to identify, monitor, and evaluate potential signals immediately using complete Electronic Medical Record data, updated daily for more than 50 million people. Truveta today announced a strategic collaboration with...
by Truveta Research | Jun 21, 2022 | Research, Research Insights
Long COVID is a term used to describe patients with returning or sustained symptoms following a SARS-CoV-2 infection. Physicians and researchers have described numerous post COVID-19 complications, including cardiovascular, coagulation and hematologic,...
